GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brain+ AS (OCSE:BRAINP) » Definitions » Total Long-Term Assets

Brain+ AS (OCSE:BRAINP) Total Long-Term Assets : kr31.55 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Brain+ AS Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Brain+ AS's Total Long-Term Assets for the quarter that ended in Dec. 2023 was kr31.55 Mil.


Brain+ AS Total Long-Term Assets Historical Data

The historical data trend for Brain+ AS's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain+ AS Total Long-Term Assets Chart

Brain+ AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Assets
22.41 27.81 33.56 36.96 31.55

Brain+ AS Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Long-Term Assets Get a 7-Day Free Trial 33.56 35.55 36.96 37.24 31.55

Brain+ AS Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.


Brain+ AS Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Brain+ AS's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Brain+ AS (OCSE:BRAINP) Business Description

Traded in Other Exchanges
N/A
Address
Kobmagergade 53, 3rd Floor, Copenhagen, DNK, DK-1150
Brain+ AS is a digital therapeutics company. It restores patients' quality of life by treating and detecting a cognitive decline in Alzheimer's disease and dementia through digital means. It has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI).

Brain+ AS (OCSE:BRAINP) Headlines

No Headlines